These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 18389330
1. Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N. Heart Vessels; 2008 Mar; 23(2):75-82. PubMed ID: 18389330 [Abstract] [Full Text] [Related]
2. Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation. Li JJ, Zhang YP, Wang C, Gao LJ, Qin XW, Xu B, Chen JL, Yang YJ, Gao RL. Coron Artery Dis; 2009 Jan; 20(1):65-70. PubMed ID: 19018239 [Abstract] [Full Text] [Related]
3. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents. Rathore S, Kinoshita Y, Terashima M, Katoh O, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T. EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201 [Abstract] [Full Text] [Related]
4. Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents. Kang WC, Ahn TH, Moon CI, Han SH, Shin EK, Kim JS, Ko YG, Choi D, Jang Y, Kim BK, Oh SJ, Jeon DW, Yang JY. Heart; 2009 Jun; 95(12):970-5. PubMed ID: 18772180 [Abstract] [Full Text] [Related]
5. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC, Otto S, Gassdorf J, Nitsche K, Janiak F, Scheller B, Goebel B, Jung C, Figulla HR. Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [Abstract] [Full Text] [Related]
6. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. Simsek C, Magro M, Boersma E, Onuma Y, Nauta ST, Gaspersz MP, van der Giessen WJ, van Domburg RT, Serruys PW, Interventional Cardiologists of the Thoraxcenter. JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464 [Abstract] [Full Text] [Related]
7. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis. Nishihira K, Shibata Y, Ishikawa T, Nomura K, Nakama T, Mine D, Inoue Y, Ashikaga K, Kuriyama N, Matsuyama A, Imamura T, Asada Y, Kitamura K. Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050 [Abstract] [Full Text] [Related]
8. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON). Rozenman Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll HP, Spaulding C. EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979 [Abstract] [Full Text] [Related]
9. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Takarada S, Tanaka A, Nakamura N, Mizukoshi M, Tomobuchi Y, Akasaka T. JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470 [Abstract] [Full Text] [Related]
10. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Yano H, Horinaka S, Yagi H, Ishimitsu T. Heart Vessels; 2013 May; 28(3):308-15. PubMed ID: 22526379 [Abstract] [Full Text] [Related]
11. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter. Obata JE, Nakamura T, Kitta Y, Saito Y, Sano K, Fujioka D, Kawabata K, Kugiyama K. Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):E777-87. PubMed ID: 23378231 [Abstract] [Full Text] [Related]
12. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels. Kim JY, Ko YG, Shim CY, Park S, Hwang KC, Choi D, Jang Y, Chung N, Shim WH, Cho SY. Am J Cardiol; 2005 Nov 15; 96(10):1384-8. PubMed ID: 16275183 [Abstract] [Full Text] [Related]
13. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Ishii H, Toriyama T, Aoyama T, Takahashi H, Amano T, Hayashi M, Tanaka M, Kawamura Y, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T. Circ Cardiovasc Interv; 2009 Dec 15; 2(6):513-8. PubMed ID: 20031768 [Abstract] [Full Text] [Related]
14. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans. Papafaklis MI, Bourantas CV, Theodorakis PE, Katsouras CS, Naka KK, Fotiadis DI, Michalis LK. JACC Cardiovasc Interv; 2010 Nov 15; 3(11):1181-9. PubMed ID: 21087755 [Abstract] [Full Text] [Related]
15. Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study. Atary JZ, Bergheanu SC, van der Hoeven BL, Atsma DE, Bootsma M, van der Kley F, Zeppenfeld K, Jukema JW, Schalij MJ. EuroIntervention; 2009 Nov 15; 5(5):565-72. PubMed ID: 20142177 [Abstract] [Full Text] [Related]
16. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study. Rodriguez AE, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Rodriguez Granillo AM, Rodriguez-Granillo GA, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios IF, Serruys PW, ORAR III Investigators. EuroIntervention; 2009 Jun 15; 5(2):255-64. PubMed ID: 20449934 [Abstract] [Full Text] [Related]
17. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. van Domburg RT, Daemen J, Morice MC, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, van Es GA, Wittebols K, Macours N, Stoll HP, Serruys PW. EuroIntervention; 2010 Apr 15; 5(8):962-7. PubMed ID: 20542782 [Abstract] [Full Text] [Related]
18. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W. JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1026-34. PubMed ID: 24055443 [Abstract] [Full Text] [Related]
19. Do drug elution components increase the risk of fracture of sirolimus-eluting stents? Kawai T, Umeda H, Ota M, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Naruse H, Matsui S, Ishii J, Hishida H, Ozaki Y. Coron Artery Dis; 2010 Aug 15; 21(5):298-303. PubMed ID: 20617542 [Abstract] [Full Text] [Related]
20. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial. Kume T, Waseda K, Koo BK, Yock PG, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Hai KT, Honda Y, Abizaid A, Fitzgerald PJ. Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):19-24. PubMed ID: 23413202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]